A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

Authors:
Open Access
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • National Institute of Mental Health
  • Office of Science
  • National Institute on Drug Abuse
  • Argonne National Laboratory (DE-AC02-06CH11357)
  • American Association for Cancer Research (SU2C-AACR-DT-27-17)
  • Hyundai Hope On Wheels
  • National Heart, Lung, and Blood Institute
  • Alex's Lemonade Stand Foundation for Childhood Cancer
  • U.S. Department of Energy
  • St. Baldrick's Foundation
  • National Institute of General Medical Sciences (AGM-12006)
  • National Institute of Neurological Disorders and Stroke
  • Damon Runyon Cancer Research Foundation (PST-07-16)
  • National Institutes of Health (S10 OD012289)
  • Evans Medical Foundation
  • National Human Genome Research Institute
  • Canada Research Chairs (950-231604)
  • National Cancer Institute (ACB-12002, K08 CA230223, U54 CA232568, R35 CA220500)

This publication has 63 references indexed in Scilit: